NCT02930473

Brief Summary

This study aims to evaluate the efficacy of a psychotherapeutic intervention model in nursing on the nursing diagnosis "Anxiety". A randomised controlled trial will be carried out to do so.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
133

participants targeted

Target at P50-P75 for not_applicable anxiety

Timeline
Completed

Started Nov 2016

Shorter than P25 for not_applicable anxiety

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 5, 2016

Completed
8 months until next milestone

First Posted

Study publicly available on registry

October 12, 2016

Completed
20 days until next milestone

Study Start

First participant enrolled

November 1, 2016

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2017

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2017

Completed
Last Updated

May 16, 2017

Status Verified

May 1, 2017

Enrollment Period

5 months

First QC Date

February 5, 2016

Last Update Submit

May 12, 2017

Conditions

Keywords

PsychotherapyNursingNursing CareNursing ModelRandomised Controlled Trial

Outcome Measures

Primary Outcomes (1)

  • Change in the Level of Anxiety (NOC outcomes "Anxiety Level" and "Anxiety Self-Control" - Portuguese version)

    At the beginning of the study (Session 0) and one week after session 5 (approximately 6 weeks after the beginning of the study)

Study Arms (2)

Psychotherapeutic Intervention(s) for Anxiety

EXPERIMENTAL

People diagnosed with "Anxiety" (according to ICNP/NANDA standardized nursing language) will be treated using Nursing Interventions Classification (NIC) psychotherapeutic intervention(s) for anxiety (plus psychopharmaceuticals).

Behavioral: NIC Psychotherapeutic Intervention(s) for AnxietyDrug: Psychopharmaceuticals (any drugs prescribed by the psychiatrist)

Treatment-as-Usual for Anxiety

ACTIVE COMPARATOR

People diagnosed with "Anxiety" (according to ICNP/NANDA standardized nursing language) will receive treatment as usual for anxiety (psychopharmaceuticals).

Drug: Psychopharmaceuticals (any drugs prescribed by the psychiatrist)

Interventions

Patients will be treated by NIC psychotherapeutic intervention(s) for anxiety (e.g. anxiety reduction) plus psychopharmaceuticals prescribed by their psychiatrist.

Psychotherapeutic Intervention(s) for Anxiety

Patients will be treated only by psychopharmaceuticals prescribed by their psychiatrist.

Psychotherapeutic Intervention(s) for AnxietyTreatment-as-Usual for Anxiety

Eligibility Criteria

Age18 Years - 64 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • years old;
  • Nursing Diagnosis "Anxiety" (according to ICNP/NANDA standardized nursing language) - assessment using NOC outcome "Anxiety Level" (Portuguese version);
  • Elementary education (completed).

You may not qualify if:

  • Psychiatric diagnosis of dementia or psychotic spectrum disorder;
  • Being in therapy provided by a psychologist (at the moment of the session 0);
  • Cognitive impairment (assessment using Mini-Mental State Examination);
  • Moderate or severe intellectual disability;
  • Confusional state;
  • Psychomotor agitation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Sampaio FMC, Araujo O, Sequeira C, Lluch Canut MT, Martins T. A randomized controlled trial of a nursing psychotherapeutic intervention for anxiety in adult psychiatric outpatients. J Adv Nurs. 2018 May;74(5):1114-1126. doi: 10.1111/jan.13520. Epub 2018 Jan 25.

MeSH Terms

Conditions

Anxiety Disorders

Interventions

Psychotropic Drugs

Condition Hierarchy (Ancestors)

Mental Disorders

Intervention Hierarchy (Ancestors)

Central Nervous System AgentsTherapeutic UsesPharmacologic ActionsChemical Actions and Uses

Study Officials

  • Francisco Sampaio, MSc

    Instituto de Ciências Biomédicas Abel Salazar da Universidade do Porto

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
RMN, MSc, PhD Student

Study Record Dates

First Submitted

February 5, 2016

First Posted

October 12, 2016

Study Start

November 1, 2016

Primary Completion

April 1, 2017

Study Completion

May 1, 2017

Last Updated

May 16, 2017

Record last verified: 2017-05

Data Sharing

IPD Sharing
Will not share